Vivo Capital, LLC logo

Vivo Capital, LLC Portfolio Analytics

Investment Analysis & Holdings Breakdown

Comprehensive portfolio analytics for Vivo Capital, LLC with $1.2B in long positions as of Q3 2025, 81% allocated to Healthcare, and 58% concentrated in top 10 positions.

Portfolio Value
$1.2B
Top 10 Concentration
58%
Top Sector
Healthcare (81%)
US Exposure
90%
Market Cap Focus
Small Cap
Countries
5

Composition Analysis

Portfolio breakdown by sector, industry, and market capitalization

Sector Allocation

Healthcare: 81.00%Healthcare
Healthcare
81.00%

Industry Breakdown

4 industries across all sectors

Biotechnology: 75.49%BiotechnologyDrug Manufacturers - Specialty & Generic: 3.30%Medical - Diagnostics & Research: 1.77%Medical - Specialties: 0.49%
Biotechnology
Healthcare
75.49%
Drug Manufacturers - Specialty & Generic
Healthcare
3.30%
Medical - Diagnostics & Research
Healthcare
1.77%
Medical - Specialties
Healthcare
0.49%

Filter by Sector

Select a sector to filter industries

Market Cap Distribution

Mid Cap ($2B - $10B): 27.83%Mid Cap ($2B - $10B)Small Cap ($300M - $2B): 43.75%Small Cap ($300M - $2B)Micro Cap ($50M - $300M): 5.66%Nano Cap (< $50M): 4.80%N/A (ETF or Unknown): 17.95%N/A (ETF or Unknown)
Mid Cap ($2B - $10B)
27.83%
Small Cap ($300M - $2B)
43.75%
Micro Cap ($50M - $300M)
5.66%
Nano Cap (< $50M)
4.80%
N/A (ETF or Unknown)
17.95%

Portfolio Concentration

Top 10 Holdings %
58.0%
Top 20 Holdings %
79.74%
Top 50 Holdings %
100.0%
Top 100 Holdings %
100.0%

Geographic Exposure

Portfolio breakdown by country of incorporation

Domestic (US)
90.33%
International
9.67%
Countries
5
Largest Int'l Market
Ireland - 3.30%
United States of America
90.33% ($1.1B)
43 holdings
Ireland
3.30% ($41.0M)
1 holdings
China
3.07% ($38.2M)
1 holdings
Canada
2.45% ($30.4M)
1 holdings
France
0.85% ($10.5M)
1 holdings

Holding Behavior

Investment patterns and position management analysis

Portfolio Stability & Commitment

Avg. Top 10
10.4 quarters
Avg. Top 20
9 quarters
Avg. All Positions
7.7 quarters
Median Holding Period
5 quarters
Persistence Rate
61.7%
Persistent Holdings Weight
69.04%
Persistent Positions
29
Longest Held
Precision BioSciences, Inc. Common Stock logo
Precision BioSciences, Inc. Common StockDTIL - 22 quarters

Position Sizing & Influence

Current Quarter

Avg. New Position
1.19%
Avg. Position Weight
2.13%
Largest Position
Soleno Therapeutics, Inc. Common Stock logo
Soleno Therapeutics, Inc. Common StockSLNO - 12.39%
Largest Ownership Stake
SAB Biotherapeutics, Inc. Common Stock logo
SAB Biotherapeutics, Inc. Common StockSABS - 100.00%
Avg. Ownership Stake
5.08%
Ownership Stake >5%
9
Ownership Stake >1%
35

Historical (Since Q1 2016)

Avg. New Position
3.75%
Avg. Ownership Stake
6.22%
Largest Position
Aclaris Therapeutics, Inc. logo
Aclaris Therapeutics, Inc.ACRS - 66.22% (Q3 2016)
Largest Ownership Stake
SAB Biotherapeutics, Inc. Common Stock logo
SAB Biotherapeutics, Inc. Common StockSABS - 100.00% (Q3 2025)

Portfolio Turnover

Current Quarter

Turnover Ratio
14.6%
Value Traded
$181.97M
Positions Added
8
Positions Exited
3

Historical (Since Q1 2016)

Avg. Turnover Ratio
14.8%
Avg. Positions Added
5
Avg. Positions Exited
4
Highest Turnover
50.0%
Q1 2016
Lowest Turnover
1.5%
Q3 2016

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.